Pietro Antonio Tataranni, MD
Deputy Chief Scientific Officer and Senior Vice President of Life Sciences for PepsiCo R&D, USA
Dr. Pietro Antonio Tataranni is the Deputy Chief Scientific Officer and Senior Vice President of Life Sciences for PepsiCo R&D. Dr. Tataranni joined PepsiCo in September 2018 and is responsible for leading the development and execution of a nutrition and bio-sciences strategy in support of the company’s portfolio transformation and Winning with Purpose agenda.
Prior to joining PepsiCo, Dr. Tataranni was Senior Vice President, Head of Global Medical Affairs, Diabetes & Cardiovascular Business Unit at Sanofi, where he was in charge of medical strategy worldwide and operations for mature markets. Previous responsibilities within the group included the roles of Vice President Global Medical Affairs, Medical Director Europe, Vice President for the Metabolism Medical Unit in the US affiliate (2006-2008), and Medical Director for the Metabolism Franchise (2005-2006). Between 1999 and 2004, he was Head of the Obesity, Diabetes and Energy Metabolism Unit at the Phoenix Epidemiology and Clinical Research Branch of the National Institutes of Health in the US and Director of the Clinical Research Center at the same institution from 2000 through 2004.
Dr. Tataranni is an avid researcher who has published and lectured extensively at national and international meetings on obesity, diabetes, and their cardiometabolic complications. He has authored more than 100 original manuscripts, in addition to contributing to numerous review articles and book chapters. Professional awards presented to Dr. Tataranni include the NIH Fellowship Award for Research Excellence (FARE) in 1998 and the North American Association for the Study of Obesity (NAASO)-Lilly Scientific Achievement Award in 2004.
Dr. Tataranni is a native of Italy. He graduated from Catholic University School of Medicine in Rome in 1990 and went on to receive a specialty diploma in Endocrinology, Metabolic Diseases and Diabetes there.